Microchimerism does not induce tolerance and sustains immunity after in utero transplantation

被引:30
作者
Donahue, J
Gilpin, E
Lee, TH
Busch, MP
Croft, M
Carrier, E
机构
[1] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA
[2] Marrow Transplantat Div, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA
[4] Univ Calif San Diego, Sch Med, Dept Family & Prevent Med, La Jolla, CA 92093 USA
[5] Univ Calif San Francisco, Sch Med, Dept Lab Med, San Francisco, CA USA
[6] La Jolla Inst Allergy & Immunol, La Jolla, CA USA
关键词
D O I
10.1097/00007890-200102150-00004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Background. To date, over 40 in utero transplants have been performed in humans; the only successes were documented in the treatment of severe combined immunodeficiency syndromes. Hemoglobinopathies and metabolic disorders are candidate diseases for this approach; however, when applied clinically, the results have been discouraging. To address the role of the fetal immune system in the outcome of in utero transplantation, we have developed a murine model of in utero transplantation in immunologically intact murine recipients and have studied chimerism and tolerance/immunity to allogeneic donor cells through the lives of the animals. Methods. We have performed experiments in which purified murine sca-1(+)/lin(-) cells and c-kit(+)/lin(-) cells of C57BL/6 (H2(b)) mice were injected into Balb/c (H2(d)) fetal recipients at early gestational ages. Chimerism was tested by highly sensitive semiquantitative polymerase chain reaction assay and tolerance/immunity to donor cells was studied by in vivo (skin grafts, responses to postnatal boosts) and in vitro (mixed lymphocyte culture, cytotoxicity, and cytokine release) assays. Results. One hundred pet-cent (10/10) of mice transplanted with c-kit(+) cells and 44% (4/9) of mice transplanted with sca(+) cells showed circulating donor cells within the first 6 months of life (P=0.031). Mice in the sca(+) group rejected donor skin grafts at a mean time of 9.1+/-0.2 days, whereas mice in the c-kit(+) group rejected donor skin grafts at a mean time of 15.1+/-0.7 days P=0.001). The difference between the transplanted groups and non-transplanted controls was also significant (P<0.05). All mice transplanted with sca(+)/lin(-) cells showed greater response to donor cells than to third-party cells at all effector to target ratios (P=0.002). Differences in response to donor alloantigen between sca(+) and c-kit(+) groups were significant P=0.003). Cytokine quantification demonstrated higher TH1 than TH2 cytokine release in all groups, and the response to donor cells was higher in the sca(+) compared with c-kit(+) mice (P=0.031). Conclusion, These results demonstrate a low level of chimerism and tolerance in mice transplanted in utero with sca(+/)lin(-) and c-kit(+)/lin(-) cells. The possibility of active in utero immunization to donor cells is supported by accelerated skin graft rejection in mice transplanted with sca(+) cells and enhanced in vitro immune responses in mice with persistent microchimerism.
引用
收藏
页码:359 / 368
页数:10
相关论文
共 47 条
[1]
Engraftment following in utero bone marrow transplantation for globoid cell leukodystrophy [J].
Bambach, BJ ;
Moser, HW ;
Blakemore, K ;
Corson, VL ;
Griffin, CA ;
Noga, SJ ;
Perlman, EJ ;
Zuckerman, R ;
Wenger, DA ;
Jones, RJ .
BONE MARROW TRANSPLANTATION, 1997, 19 (04) :399-402
[2]
BILLINGHAM L, 1953, NATURE, V172, P4379
[3]
Blakemore K., 1996, American Journal of Obstetrics and Gynecology, V174, P312
[4]
Preemptive therapy for genetic disease [J].
Blau, CA ;
Stamatoyannopoulos, G .
NATURE MEDICINE, 1996, 2 (02) :161-162
[5]
BRIDDELL RA, 1993, BLOOD, V82, P1720
[6]
INDUCTION OF TOLERANCE IN NONDEFECTIVE MICE AFTER IN-UTERO TRANSPLANTATION OF MAJOR HISTOCOMPATIBILITY COMPLEX-MISMATCHED FETAL HEMATOPOIETIC STEM-CELLS [J].
CARRIER, E ;
LEE, TH ;
BUSCH, MP ;
COWAN, MJ .
BLOOD, 1995, 86 (12) :4681-4690
[7]
Recruitment of engrafted donor cells postnatally into the blood with cytokines after in utero transplantation in mice [J].
Carrier, E ;
Lee, TH ;
Busch, MP ;
Cowan, MJ .
TRANSPLANTATION, 1997, 64 (04) :627-633
[8]
COLIGAN JE, 1995, CURR PROTEIN IMMUNOL, V3, P1
[9]
CROFT M, 1995, J IMMUNOL, V154, P4269
[10]
Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow [J].
Flake, AW ;
Roncarolo, MG ;
Puck, JM ;
AlmeidaPorada, G ;
Evans, MI ;
Johnson, MP ;
Abella, EM ;
Harrison, DD ;
Zanjani, ED .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (24) :1806-1810